Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2026)

Cytek Biosciences filings provide 6 years of Interest & Investment Income readings, the most recent being $580000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 36.47% to $580000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 56.73% decrease, with the full-year FY2025 number at $2.2 million, down 56.73% from a year prior.
  • Interest & Investment Income hit $580000.0 in Q4 2025 for Cytek Biosciences, up from $573000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.6 million in Q4 2022 to a low of $9000.0 in Q2 2021.
  • Median Interest & Investment Income over the past 5 years was $746500.0 (2024), compared with a mean of $920950.0.
  • Biggest five-year swings in Interest & Investment Income: soared 14488.89% in 2022 and later tumbled 62.62% in 2025.
  • Cytek Biosciences' Interest & Investment Income stood at $18000.0 in 2021, then soared by 14488.89% to $2.6 million in 2022, then plummeted by 44.86% to $1.4 million in 2023, then plummeted by 36.95% to $913000.0 in 2024, then plummeted by 36.47% to $580000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $580000.0 (Q4 2025), $573000.0 (Q3 2025), and $555000.0 (Q2 2025) per Business Quant data.